-
Je něco špatně v tomto záznamu ?
Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner
K. Cizkova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- buňky Hep G2 MeSH
- buňky HT-29 MeSH
- cytochrom P450 CYP2C8 biosyntéza genetika MeSH
- deriváty kyseliny fibrové farmakologie MeSH
- epoxid hydrolasy biosyntéza MeSH
- HEK293 buňky MeSH
- hypoglykemika farmakologie MeSH
- kyseliny arachidonové metabolismus MeSH
- lidé MeSH
- PPAR alfa účinky léků metabolismus MeSH
- regulace genové exprese enzymů účinky léků MeSH
- systém (enzymů) cytochromů P-450 biosyntéza genetika MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
CYP epoxygenases metabolize arachidonic acid into four regioisomers of epoxyeicosatrienoic acids (EETs) which are hydrolysed into their corresponding diols by soluble epoxide hydrolase (sEH). EETs are very biologically active molecules. They promote proliferation and inhibit apoptosis as well as numerous other functions within organisms. Peroxisome proliferator-activated receptor α (PPARα) play role in regulation of CYP epoxygenases and sEH. PPARα is the ligand-dependent transcriptional factor which is activated by various compounds, including fibrates. The latter are widely used in clinical practice. This study investigates the changes in expression of CYP2C8, CYP2J2, and sEH in HEK293, HepG2, and HT-29 cell lines after fibrate treatment using two different incubation times. The results demonstrate that the effect of fibrates on arachidonic acid-metabolizing enzymes expression is concentration-dependent. Although CYP2C8 expression is downregulated by the fibrates treatment, the results reveal that changes in CYP2J2/sEH ratio are closely associated with cell proliferation and could explain the differing proliferation response of cells to different concentrations of fibrates.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012578
- 003
- CZ-PrNML
- 005
- 20190412122932.0
- 007
- ta
- 008
- 190405s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.taap.2018.06.025 $2 doi
- 035 __
- $a (PubMed)29960002
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cizkova, Katerina $u Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic. Electronic address: katerina.cizkova@upol.cz.
- 245 10
- $a Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner / $c K. Cizkova,
- 520 9_
- $a CYP epoxygenases metabolize arachidonic acid into four regioisomers of epoxyeicosatrienoic acids (EETs) which are hydrolysed into their corresponding diols by soluble epoxide hydrolase (sEH). EETs are very biologically active molecules. They promote proliferation and inhibit apoptosis as well as numerous other functions within organisms. Peroxisome proliferator-activated receptor α (PPARα) play role in regulation of CYP epoxygenases and sEH. PPARα is the ligand-dependent transcriptional factor which is activated by various compounds, including fibrates. The latter are widely used in clinical practice. This study investigates the changes in expression of CYP2C8, CYP2J2, and sEH in HEK293, HepG2, and HT-29 cell lines after fibrate treatment using two different incubation times. The results demonstrate that the effect of fibrates on arachidonic acid-metabolizing enzymes expression is concentration-dependent. Although CYP2C8 expression is downregulated by the fibrates treatment, the results reveal that changes in CYP2J2/sEH ratio are closely associated with cell proliferation and could explain the differing proliferation response of cells to different concentrations of fibrates.
- 650 _2
- $a kyseliny arachidonové $x metabolismus $7 D001095
- 650 _2
- $a cytochrom P450 CYP2C8 $x biosyntéza $x genetika $7 D065727
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x biosyntéza $x genetika $7 D003577
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a epoxid hydrolasy $x biosyntéza $7 D004851
- 650 _2
- $a deriváty kyseliny fibrové $x farmakologie $7 D058607
- 650 _2
- $a regulace genové exprese enzymů $x účinky léků $7 D015971
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a buňky HT-29 $7 D019073
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoglykemika $x farmakologie $7 D007004
- 650 _2
- $a PPAR alfa $x účinky léků $x metabolismus $7 D047493
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 773 0_
- $w MED00010691 $t Toxicology and applied pharmacology $x 1096-0333 $g Roč. 355, č. - (2018), s. 156-163
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29960002 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190412122951 $b ABA008
- 999 __
- $a ok $b bmc $g 1391888 $s 1050883
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 355 $c - $d 156-163 $e 20180627 $i 1096-0333 $m Toxicology and applied pharmacology $n Toxicol Appl Pharmacol $x MED00010691
- LZP __
- $a Pubmed-20190405